Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : Sny crawled date : 2022 - 03 - 08 save search
Myelodysplastic Syndrome Market to Climb Swiftly at a 13.2% CAGR During the Study Period [2018-2030], Evaluates DelveInsight
Published: 2022-03-08 (Crawled : 16:00) - prnewswire.com
LLY | News | $732.2 -1.81% 0.18% 2.1M
|
Health Technology
|
| O: -0.38%
H: 0.0%
C: 0.0%
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: 3.03%
H: 0.0%
C: 0.0%
GERN | $3.57 2.0% 1.96% 6.6M
|
Health Technology
|
| O: -0.97%
H: 5.88%
C: 1.96%
syndros
Icertis Announces Year of Record Growth
Published: 2022-03-08 (Crawled : 16:00) - prnewswire.com
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: 3.03%
H: 0.0%
C: 0.0%
ces growth
Going All In on mRNA, Sanofi Breaks Ground on New Vaccine Site
Published: 2022-03-08 (Crawled : 15:00) - biospace.com/
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: 3.03%
H: 0.0%
C: 0.0%
new vaccine vaccine
Sanofi recognized by S&P as one of the most sustainability-committed companies
Published: 2022-03-08 (Crawled : 13:30) - globenewswire.com
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: 3.03%
H: 0.0%
C: 0.0%
one
BioNTech and Regeneron Expand Strategic Collaboration to Advance Clinical Development of FixVac and Libtayo® (cemiplimab) Combination in NSCLC
Published: 2022-03-08 (Crawled : 13:30) - globenewswire.com
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: 3.03%
H: 0.0%
C: 0.0%
BNTX | News | $88.18 -0.35% -0.35% 280K
|
Health Technology
|
| O: -7.15%
H: 7.89%
C: 3.44%
libtayo collaboration
Hematological Malignancies Drugs Market worth $ 42.78 Billion by 2030 - Exclusive Report by InsightAce Analytic
Published: 2022-03-08 (Crawled : 11:00) - prnewswire.com
GNMSF | News | $290.34 3.83% 340
|
Health Technology
|
| O: -0.14%
H: 5.36%
C: 5.36%
TAK | News | $13.23 -1.12% 0.0% 920K
|
Health Technology
|
| O: -2.75%
H: 0.28%
C: -1.04%
JNJ | News | $148.53 -0.69% -0.14% 9.6M
|
Health Technology
|
| O: 1.89%
H: 0.0%
C: 0.0%
GSK | News | $40.86 -0.92% -0.15% 1.7M
|
Health Technology
|
| O: 0.38%
H: 1.81%
C: 0.28%
BMY | $48.86 -0.27% -0.02% 16M
|
Health Technology
|
| O: -1.55%
H: 0.71%
C: -0.28%
ABBV | News | $167.8 -1.03% -0.06% 4.1M
|
Health Technology
|
| O: 0.29%
H: 0.6%
C: -1.24%
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: 3.03%
H: 0.0%
C: 0.0%
GILD | $67.07 0.06% 0.06% 8.3M
|
Health Technology
|
| O: 1.4%
H: 0.7%
C: -1.15%
GMAB | News | $28.47 -0.32% -0.32% 460K
|
Health Technology
|
| O: -0.3%
H: 3.38%
C: 0.32%
AMGN | News | $273.085 -0.17% -0.17% 2.5M
|
Health Technology
|
| O: 0.35%
H: 0.0%
C: 0.0%
ema drug report
Non-small Cell Lung Cancer Drugs Market to Grow by USD 30.23 billion| Increasing Prevalence and Incidence of Non-small Cell Lung Cancer to Boost Market Growth | Technavio
Published: 2022-03-08 (Crawled : 08:00) - prnewswire.com
AZNCF | News | $140.3 -4.19% 1.5K
|
Health Technology
|
| O: -2.09%
H: 5.03%
C: 0.85%
ALPMY | News | $9.49 -1.11% 480K
|
Manufacturing
|
| O: 1.01%
H: 0.81%
C: -0.06%
NVS | News | $98.35 1.1% 0.0% 2.2M
|
Health Technology
|
| O: -4.98%
H: 0.0%
C: 0.0%
ABBV | News | $167.8 -1.03% -0.06% 4.1M
|
Health Technology
|
| O: 0.29%
H: 0.6%
C: -1.24%
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: 3.03%
H: 0.0%
C: 0.0%
AZN | News | $71.175 0.46% 0.46% 6.1M
|
Health Technology
|
| O: -0.44%
H: 0.0%
C: 0.0%
AMGN | News | $273.085 -0.17% -0.17% 2.5M
|
Health Technology
|
| O: 0.35%
H: 0.0%
C: 0.0%
drug cel lung cancer cancer drug cancer growth
Gainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M
|
Consumer Services
BOF | $1.99 70.09% 41.21% 110M
|
ILAG | $0.51 6.03% 40.62% 1.7M
|
LICN | $0.941 68.04% 40.49% 15M
|
AMST | $3.31 65.5% 39.58% 70M
|
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.45 12.5% 30.92% 320K
|
Health Services
MULN | News | $3.78 38.46% 27.78% 13M
|
Information
RILY | $29.86 37.48% 27.26% 12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.